Literature DB >> 8228936

Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection.

D D Erdman1, J L Heath, J C Watson, L E Markowitz, W J Bellini.   

Abstract

The use of IgM antibody detection for the classification of the primary and secondary measles antibody response in persons following primary and secondary vaccination and natural measles virus infection was examined. Of 32 nonimmune children receiving primary measles vaccination, 31 (97%) developed IgM antibodies, consistent with a primary antibody response. Of 21 previously vaccinated children with low levels of preexisting IgG antibodies who responded to revaccination, none developed detectable IgM antibodies, whereas 33 of 35 (94%) with no detectable preexisting IgG antibodies developed an IgM response. Of a sample of 57 measles cases with a prior history of vaccination, 55 (96%) had detectable IgM antibodies. Of these, 30 (55%) were classified as having a primary antibody response and 25 (45%) a secondary antibody response based on differences in their ratios of IgM to IgG antibodies. Differences in the severity of clinical symptoms between these 2 groups were consistent with this classification scheme. These findings suggest that 1) an IgM response follows primary measles vaccination in the immunologically naive, 2) an IgM response is absent on revaccination of those previously immunized, and 3) an IgM response may follow clinical measles virus infection independent of prior immunization status.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228936     DOI: 10.1002/jmv.1890410110

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  Measles eradication: is it in our future?

Authors:  W A Orenstein; P M Strebel; M Papania; R W Sutter; W J Bellini; S L Cochi
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003.

Authors:  Terri B Hyde; Robin Nandy; Carole J Hickman; Justina R Langidrik; Peter M Strebel; Mark J Papania; Jane F Seward; William J Bellini
Journal:  Bull World Health Organ       Date:  2009-02       Impact factor: 9.408

Review 4.  Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection.

Authors:  J Erin Staples; Alan D T Barrett; Annelies Wilder-Smith; Joachim Hombach
Journal:  NPJ Vaccines       Date:  2020-07-06       Impact factor: 7.344

5.  Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease.

Authors:  Freddy Caldera; Elizabeth Ann Misch; Sumona Saha; Arnold Wald; Youqi Zhang; Jeffrey Hubers; Bryant Megna; Dana Ley; Mark Reichelderfer; Mary S Hayney
Journal:  Dig Dis Sci       Date:  2018-10-13       Impact factor: 3.199

6.  Children who miss immunisation: implications for eliminating measles.

Authors:  M R Evans
Journal:  BMJ       Date:  1995-05-27

7.  Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection.

Authors:  M Narita; S Yamada; Y Matsuzono; O Itakura; T Togashi; H Kikuta
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

8.  A retrospective cohort study of risk factors for missing preschool booster immunisation.

Authors:  M R Evans; D R Thomas
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

9.  Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination.

Authors:  Hong Zhao; Pei-Shan Lu; Yali Hu; Qiaozhen Wu; Wenhu Yao; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-05-06       Impact factor: 4.099

10.  Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.

Authors:  Cláudio S Pannuti; Ricardo José Morello; José Cássio de Moraes; Suely Pires Curti; Ana Maria S Afonso; Maria Cláudia Corrêa Camargo; Vanda A U F de Souza
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.